Eric Warren, Chief Commercial Officer at Mineralys Therapeutics, Inc. (MLYS), sold 7,438 shares at $26.87 ($200K) on 2026-07-21, disclosed to the SEC on 2026-07-23.
Scheduled sale ($200k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MLYS | SELL | 2026-06-30 | $2.7M | — | Filing → |
| ESPR | SELL | 2025-04-21 | $106 | — | Filing → |
| ESPR | SELL | 2025-03-19 | $4K | — | Filing → |